| Drug Name |
Ioxilan |
| Drug ID |
BADD_D01189 |
| Description |
Ioxilan is a tri-iodinated diagnostic contrast agent. Intravascular injection results in opacification of vessels in the path of flow of the contrast medium, permitting radiographic visualization of the internal structures of the human body until significant hemodilution occurs. |
| Indications and Usage |
When administered intravenously, Ioxilan is indicated for excretory urography and contrast enhanced computed tomographic (CECT) imaging of the head and body (300 and 350 mgI/mL). |
| Marketing Status |
Discontinued |
| ATC Code |
V08AB12 |
| DrugBank ID |
DB09135
|
| KEGG ID |
D02161
|
| MeSH ID |
C055357
|
| PubChem ID |
3743
|
| TTD Drug ID |
D02BLO
|
| NDC Product Code |
Not Available |
| Synonyms |
ioxilan | 5-(N-2,3-dihydroxypropylacetamido)-2,4,6-triiodo-N-(2-hydroxyethyl)-N'-(2,3-dihydroxypropyl)isophthalamide | Oxilan |
